Bath Savings Trust Co Lifted Edwards Lifesciences (EW) Holding By $789,160; Onemain Holdings (OMF) SI Decreased By 10.81%

Bath Savings Trust Co increased Edwards Lifesciences Corp (EW) stake by 116.62% reported in 2017Q3 SEC filing. Bath Savings Trust Co acquired 7,240 shares as Edwards Lifesciences Corp (EW)’s stock rose 25.80%. The Bath Savings Trust Co holds 13,448 shares with $1.47M value, up from 6,208 last quarter. Edwards Lifesciences Corp now has $24.25B valuation. The stock increased 2.70% or $3.01 during the last trading session, reaching $114.59. About 1.27 million shares traded. Edwards Lifesciences Corporation (NYSE:EW) has risen 15.41% since January 4, 2017 and is uptrending. It has underperformed by 1.29% the S&P500.

Onemain Holdings Incorporated (NYSE:OMF) had a decrease of 10.81% in short interest. OMF’s SI was 3.05M shares in January as released by FINRA. Its down 10.81% from 3.42M shares previously. With 853,000 avg volume, 4 days are for Onemain Holdings Incorporated (NYSE:OMF)’s short sellers to cover OMF’s short positions. The stock increased 1.29% or $0.34 during the last trading session, reaching $26.64. About 1.05 million shares traded or 0.96% up from the average. OneMain Holdings, Inc. (NYSE:OMF) has declined 22.76% since January 4, 2017 and is downtrending. It has underperformed by 39.46% the S&P500.

Among 18 analysts covering OneMain Holdings (NYSE:OMF), 7 have Buy rating, 0 Sell and 11 Hold. Therefore 39% are positive. OneMain Holdings has $50 highest and $19 lowest target. $32.75’s average target is 22.94% above currents $26.64 stock price. OneMain Holdings had 40 analyst reports since December 1, 2015 according to SRatingsIntel. The company was initiated on Tuesday, October 11 by Wedbush. As per Friday, October 6, the company rating was maintained by BMO Capital Markets. The company was reinitiated on Tuesday, December 1 by Citigroup. On Friday, February 26 the stock rating was downgraded by Compass Point to “Neutral”. The company was maintained on Friday, November 3 by BMO Capital Markets. Citigroup initiated the stock with “Hold” rating in Monday, October 16 report. On Tuesday, November 8 the stock rating was downgraded by Guggenheim to “Neutral”. BMO Capital Markets maintained the shares of OMF in report on Wednesday, April 12 with “Buy” rating. The stock of OneMain Holdings, Inc. (NYSE:OMF) has “Equal Weight” rating given on Thursday, November 10 by Barclays Capital. The rating was initiated by JP Morgan on Monday, September 12 with “Overweight”.

OneMain Holdings, Inc., through its subsidiaries, provides consumer finance and insurance services and products. The company has market cap of $3.61 billion. The firm operates through Consumer and Insurance, Acquisitions and Servicing, and Real Estate divisions. It has a 21.04 P/E ratio. It provides secured and unsecured personal loans; credit insurance products, such as life insurance, disability insurance, protection, and involuntary unemployment insurance products; non-credit insurance; and ancillary products, such as auto membership plans.

Among 28 analysts covering Edwards Lifesciences Corp (NYSE:EW), 20 have Buy rating, 1 Sell and 7 Hold. Therefore 71% are positive. Edwards Lifesciences Corp has $195 highest and $86 lowest target. $123.33’s average target is 7.63% above currents $114.59 stock price. Edwards Lifesciences Corp had 92 analyst reports since July 30, 2015 according to SRatingsIntel. BTIG Research downgraded Edwards Lifesciences Corporation (NYSE:EW) on Thursday, February 2 to “Neutral” rating. Jefferies maintained Edwards Lifesciences Corporation (NYSE:EW) on Friday, May 26 with “Buy” rating. The rating was maintained by Jefferies on Tuesday, September 5 with “Buy”. The firm has “Sell” rating by Citigroup given on Thursday, November 12. Barclays Capital maintained the shares of EW in report on Wednesday, October 25 with “Equal-Weight” rating. The rating was maintained by Stifel Nicolaus with “Buy” on Wednesday, April 26. Bank of America upgraded Edwards Lifesciences Corporation (NYSE:EW) rating on Thursday, July 27. Bank of America has “Buy” rating and $15000 target. Deutsche Bank maintained Edwards Lifesciences Corporation (NYSE:EW) on Thursday, October 26 with “Hold” rating. RBC Capital Markets maintained the stock with “Outperform” rating in Wednesday, February 3 report. The firm has “Buy” rating by Bank of America given on Wednesday, July 27.